Shagun Singh Chadha
Stock Analyst at RBC Capital
(0.63)
# 3,928
Out of 4,417 analysts
640
Total ratings
44%
Success rate
-1.7%
Average return
Main Sectors:
Stocks Rated by Shagun Singh Chadha
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Reiterated: Buy | $100 | $88.58 | +12.89% | 51 | Jun 15, 2026 | |
| PEN Penumbra | Maintained: Hold | $374 | $318.46 | +17.44% | 38 | Jun 11, 2026 | |
| MDT Medtronic | Reiterated: Buy | $118 | $81.32 | +45.11% | 46 | Jun 3, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $100 | $46.92 | +113.13% | 56 | May 27, 2026 | |
| PODD Insulet | Maintained: Buy | $280 | $147.69 | +89.59% | 17 | May 27, 2026 | |
| DXCM DexCom | Reiterated: Buy | $85 | $73.16 | +16.18% | 27 | May 15, 2026 | |
| TFX Teleflex | Upgraded: Buy | $135 → $155 | $127.87 | +21.22% | 50 | May 8, 2026 | |
| OM Outset Medical | Reiterated: Hold | $7 | $4.42 | +58.37% | 39 | May 8, 2026 | |
| BDX Becton, Dickinson and Company | Maintained: Hold | $175 | $145.16 | +20.56% | 11 | May 7, 2026 | |
| GMED Globus Medical | Maintained: Buy | $115 → $120 | $77.52 | +54.80% | 39 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $16.69 | +79.75% | 19 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $56 → $45 | $41.39 | +8.72% | 27 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $435 | $310.58 | +40.06% | 46 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $101 | $89.33 | +13.06% | 40 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $650 | $417.07 | +55.85% | 46 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $135 → $130 | $90.62 | +43.46% | 42 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $255 → $265 | $235.18 | +12.68% | 45 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $74 | $17.71 | n/a | 1 | Apr 29, 2021 |
Edwards Lifesciences
Jun 15, 2026
Reiterated: Buy
Price Target: $100
Current: $88.58
Upside: +12.89%
Penumbra
Jun 11, 2026
Maintained: Hold
Price Target: $374
Current: $318.46
Upside: +17.44%
Medtronic
Jun 3, 2026
Reiterated: Buy
Price Target: $118
Current: $81.32
Upside: +45.11%
Boston Scientific
May 27, 2026
Maintained: Buy
Price Target: $100
Current: $46.92
Upside: +113.13%
Insulet
May 27, 2026
Maintained: Buy
Price Target: $280
Current: $147.69
Upside: +89.59%
DexCom
May 15, 2026
Reiterated: Buy
Price Target: $85
Current: $73.16
Upside: +16.18%
Teleflex
May 8, 2026
Upgraded: Buy
Price Target: $135 → $155
Current: $127.87
Upside: +21.22%
Outset Medical
May 8, 2026
Reiterated: Hold
Price Target: $7
Current: $4.42
Upside: +58.37%
Becton, Dickinson and Company
May 7, 2026
Maintained: Hold
Price Target: $175
Current: $145.16
Upside: +20.56%
Globus Medical
May 7, 2026
Maintained: Buy
Price Target: $115 → $120
Current: $77.52
Upside: +54.80%
May 7, 2026
Maintained: Buy
Price Target: $30
Current: $16.69
Upside: +79.75%
May 4, 2026
Reiterated: Hold
Price Target: $56 → $45
Current: $41.39
Upside: +8.72%
May 1, 2026
Reiterated: Buy
Price Target: $435
Current: $310.58
Upside: +40.06%
Apr 28, 2026
Maintained: Buy
Price Target: $101
Current: $89.33
Upside: +13.06%
Apr 21, 2026
Reiterated: Buy
Price Target: $650
Current: $417.07
Upside: +55.85%
Apr 16, 2026
Reiterated: Buy
Price Target: $135 → $130
Current: $90.62
Upside: +43.46%
Apr 14, 2026
Maintained: Buy
Price Target: $255 → $265
Current: $235.18
Upside: +12.68%
Apr 29, 2021
Maintained: Hold
Price Target: $74
Current: $17.71
Upside: n/a